ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2026
High early complication risk but low risk of re-revision beyond 5 years following revision knee arthroplasty in the elderly: An analysis of 2833 cases using real-world data from an international database.
Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparative effectiveness of antimicrobial implant surface coatings in preventing orthopaedic implant-associated infections: a network meta-analysis.Archives of orthopaedic and trauma surgery · 2026Pooled it
- Low all-cause 90-day mortality after revision knee arthroplasty: A study based on the Swedish Perioperative Register (SPOR), 2017-2022.Journal of experimental orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeWith an increasing global elderly population, the number of revision total knee arthroplasties (rTKAs) in patients aged ≥80 years is rising. However, outcomes in this age group remain difficult to report and poorly understood. This study aimed to evaluate clinical outcomes, 90-day complication rates and long-term implant survivorship after rTKA in patients aged ≥80 years, and to compare results between revisions for aseptic loosening and prosthetic joint infection (PJI).
methodsData were extracted from TriNetX, a global healthcare database covering 21 countries. Patients aged ≥80 years undergoing rTKA were included. Outcomes assessed included 90-day complications and mortality, crude re-revision rates at 2, 5 and 10 years, and implant and patient survivorship. Propensity score-matched analysis compared outcomes between aseptic loosening and PJI cohorts. Cox regression identified predictors of 90-day mortality and 2-year re-revision risk.
resultsA total of 2833 patients were included. Ninety-day mortality was 2.7%. Acute kidney injury (AKI) was the most frequent complication (9.9%), particularly among PJI patients (18.2%). Crude re-revision rates were 9.3%, 10.4% and 10.5% at 2, 5 and 10 years, respectively, while implant survivorship was 87.7%, 83.6% and 81.8%. Ten-year patient survivorship was 38.8%. Patients with PJI had higher comorbidity burdens and postoperative complication rates. After matching, PJI patients showed increased risk of 90-day mortality (relative risk [RR] = 2.00, p = 0.051) and AKI (RR = 1.91, p < 0.001). Cox regression confirmed PJI as an independent predictor of 90-day mortality (hazard ratio [HR] = 2.51, p = 0.008) and 2-year re-revision (HR = 1.70, p = 0.001).
conclusionsElderly patients undergoing rTKA for PJI exhibit greater comorbidity, higher complication rates and increased early mortality compared to those revised for aseptic loosening. Re-revision beyond 5 years is uncommon. In this population, outcomes such as mortality, mobility and quality of life may be more clinically meaningful than long-term implant survivorship. LEVEL OF EVIDENCE: Level IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.